Research Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021 Across multiple indications, physicians anticipate 2021 will be an exciting year for advancing treatments across autoimmune and auto-inflammatory conditions.In a study conducted by ZoomRx late December 2020, 107 practicing U.S. rheumatologists
Covid-19 Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Understand how neurology departments across the US and Canada are rapidly adapting their clinical care delivery systems to minimize risk of SARS-CoV-2 transmission.
Covid-19 COVID-19: Physician Perspective on Efforts to Address Health Inequity Evidence shows that the ongoing COVID-19 pandemic disproportionately impacts Black Americans. Here are some recommendations from physicians to advocate for heath equity.
Covid-19 COVID-19 Impact on US Commercial Payers Throughout the COVID outbreak, health plans have collectively gone to great lengths to provide coverage in an urgent and unexpected situation. Plans have rapidly adapted to current healthcare needs...
Covid-19 COVID-19: Impact on Healthcare Practices and Treatment Decisions The evolving COVID-19 pandemic is causing enormous impact on individuals and the healthcare system. Increasingly, it is also clear that COVID-19 has broad-ranging effects on our workplaces, our economy, and our social interactions.
Research ZoomRx, MGH, and the Sumaira Foundation Collaborate on Newly Published NMO Research When approached by the Global Neurology Research Group at Mass General Hospital (along with the Sumaira Foundation) with the opportunity to collaborate on a global study of neuromyelitis optica (NMO), we were eager
